KPNA2 and hepatocellular carcinoma: Previous studies have shown that KPNA2 promotes the advancement of HCC by interfering with the cell cycle and increasing the expression of CCNB2 (cyclin B2)/CDK1 (cyclin-dependent kinase 1).